Anika Therapeutics reported $8.68M in Trade Creditors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 4.46M 4.01M
Acorda Therapeutics ACOR:US $ 47.61M 35.46M
Adamas Pharmaceuticals ADMS:US 2.14M 2.57M
Agenus AGEN:US $ 19.48M 2.46M
Agios Pharmaceuticals AGIO:US $ 51.22M 24.38M
Anika Therapeutics ANIK:US $ 8.68M 0.3M
Arrowhead Research ARWR:US $ 5.3M 0.47M
Clovis Oncology CLVS:US $ 20.5M 6.19M
Dicerna Pharmaceuticals DRNA:US $ 11.28M 3.38M
Enanta Pharmaceuticals ENTA:US $ 5.7M 0.61M
Halozyme Therapeutics HALO:US $ 1.93M 1.5M
Heron Therapeutics HRTX:US $ 1.69M 1.16M
Insmed INSM:US $ 22.42M 20.43M
Integra Lifesciences IART:US $ 61.5M 6.89M
Johnson & Johnson JNJ:US $ 8503M 1002M
Karyopharm Therapeutics KPTI:US $ 3.04M 1.41M
Macrogenics MGNX:US $ 10.35M 2.32M
Merit Medical Systems MMSI:US $ 52.99M 3.15M
Rigel Pharmaceuticals RIGL:US $ 5.1M 1.39M
Sangamo Biosciences SGMO:US 11.64M 915K
Stryker SYK:US $ 767M 43M
Surmodics SRDX:US $ 1.59M 0.73M
Veracyte VCYT:US $ 3.12M 1.18M
Xencor XNCR:US $ 7.66M 1.29M